These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15465274)
1. Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition. Richter-Landsberg C; Bauer NG Int J Dev Neurosci; 2004 Nov; 22(7):443-51. PubMed ID: 15465274 [TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. Goldbaum O; Oppermann M; Handschuh M; Dabir D; Zhang B; Forman MS; Trojanowski JQ; Lee VM; Richter-Landsberg C J Neurosci; 2003 Oct; 23(26):8872-80. PubMed ID: 14523089 [TBL] [Abstract][Full Text] [Related]
3. Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture. Goldbaum O; Richter-Landsberg C J Neurosci; 2004 Jun; 24(25):5748-57. PubMed ID: 15215297 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance. Leyk J; Goldbaum O; Noack M; Richter-Landsberg C J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725 [TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467 [TBL] [Abstract][Full Text] [Related]
6. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Dabir DV; Trojanowski JQ; Richter-Landsberg C; Lee VM; Forman MS Am J Pathol; 2004 Jan; 164(1):155-66. PubMed ID: 14695329 [TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. Riedel M; Goldbaum O; Richter-Landsberg C J Mol Neurosci; 2009 Sep; 39(1-2):226-34. PubMed ID: 19266322 [TBL] [Abstract][Full Text] [Related]
8. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration. Richter-Landsberg C Biol Chem; 2016 Mar; 397(3):185-94. PubMed ID: 26083267 [TBL] [Abstract][Full Text] [Related]
9. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372 [TBL] [Abstract][Full Text] [Related]
10. αB-crystallin and HSP27 in glial cells in tauopathies. López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029 [TBL] [Abstract][Full Text] [Related]
11. The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress. Bauer NG; Richter-Landsberg C J Mol Neurosci; 2006; 29(2):153-68. PubMed ID: 16954605 [TBL] [Abstract][Full Text] [Related]
12. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases. Seiberlich V; Goldbaum O; Zhukareva V; Richter-Landsberg C Biochim Biophys Acta; 2012 Nov; 1823(11):2057-68. PubMed ID: 22565157 [TBL] [Abstract][Full Text] [Related]
13. Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration. Majumder M; Dutta D Cells; 2024 Jun; 13(13):. PubMed ID: 38994964 [TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. Wilhelmus MM; de Jager M; Rozemuller AJ; Brevé J; Bol JG; Eckert RL; Drukarch B J Pathol; 2012 Jan; 226(1):132-42. PubMed ID: 22009441 [TBL] [Abstract][Full Text] [Related]
15. Exon 3 insert of tau protein in neurodegenerative diseases. Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
17. The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease. Richter-Landsberg C J Mol Neurosci; 2008 May; 35(1):55-63. PubMed ID: 18058074 [TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes. Goldbaum O; Vollmer G; Richter-Landsberg C Glia; 2006 Jun; 53(8):891-901. PubMed ID: 16609961 [TBL] [Abstract][Full Text] [Related]
19. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Goedert M Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313 [TBL] [Abstract][Full Text] [Related]